Nymox Pharmaceutical Corporation (NYMX) Slipped -5.28% or -0.14 To Price $2.51 On Monday


Nymox Pharmaceutical Corporation (NYMX) slipped -5.28% or -0.14 to $2.51. It is around 61071 shares traded, which is 62.15% compare to the average total volume 98267. The market cap of NYMX is $152.46 million. The year to date change is -25.94%. The 52 week price range is from $2.51 to $4.6. Price of NYMX have changed -14.24% during last week. It have changed -22.97% over last month, -30.63% over last 3 months, -16.93% over last 6 months and -23.41% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NYMX is 3.32. It is 32.27% above current price. The 200-day Moving Averages for NYMX is 3.57. It is 42.23% above current price. The 52-week High is 4.6. It is 83.27% from the current price. The 52-week Low is 2.51. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NYMX is 21.34 on 2018-07-31. Short % to float is 3.64%. There are some statistics of NYMX. It is has market cap $152.46 million. The share outstanding is 60.74 million. The average volume is 98267. The percent of top 15 Institution holding is 6.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NYMX is -917.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NYMX is -400.44%.


Tags:

Share this post